-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Who Are the Patients at High Risk of Recurrent Thrombosis?

Program: Education Program
Session: Diagnostic and Prognostic Models in VTE Management: Ready for Primetime?
Hematology Disease Topics & Pathways:
Adult, Diseases, Bleeding and Clotting, Biological Processes, Pregnancy, Thromboembolism, Study Population, Clinically relevant, Thrombotic Disorders, VTE
Saturday, December 5, 2020, 9:25 AM-9:30 AM

Fionnuala Ni Ainle, MD, PhD

Department of Hematology, Mater Misericordiae University Hospital and Rotunda Hospital, University College Dublin, Dublin, Ireland

Disclosures: Ainle: Sanofi: Research Funding; Leo Pharma: Research Funding; Actelion: Research Funding; Bayer: Research Funding.

See more of: Diagnostic and Prognostic Models in VTE Management: Ready for Primetime?
See more of: Education Program
<< Previous Presentation | Next Presentation >>